ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Fang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.